Issue link: https://viewer.e-digitaledition.com/i/889419
WORTH THE COST The two-year-long process of creating the new Medical Care Guidelines for Adults with Down Syndrome is costly. Global Down Syndrome Foundation has committed to funding this important initiative, translating the guidelines into 10 languages, and updating them every five years. Global is reaching out to the Down syndrome community for donations, and so far, 28 Down syndrome organizations and multiple individuals have contributed. Their generosity will be recognized in the published guidelines. "Research is expensive," said Dennis McGuire, Ph.D., LCSW, Senior Consultant at Global. "Many groups have already stepped up to help fund the guidelines. They know how important this is and are very excited." Your ongoing support is crucial to ensuring the best-quality guidelines. To donate, visit globaldownsyndrome.org/donate-adult- med-care. those can present as behavioral change. When people come in with changes in behavior, behavioral health professionals will recommend a thorough physical exam to make sure there are no physiological issues. If we're treating depression without treating its physical causes, we're not really helping [someone with Down syndrome]." VETTING THE DATA The first step in the creation of the new guidelines is a rigorous research process by the ECRI Institute, a nonprofit organization that conducts research to create evidence-based medical guidelines. ECRI works closely with the U.S. Department of Health and Human Services' National Guideline Clearinghouse, which validates the guidelines. "After that, we'll gather information from the researchers and clinicians, put it into the form of actual guidelines, and make certain they are published in medical journals," Dr. McGuire said. "ECRI's role is to make sure that the quality of this process is extremely high." The project has attracted leading medical professionals from throughout the U.S. who provide clinical care to thousands of adult patients with Down syndrome every year. These clinicians will use the ECRI-vetted data as a basis to apply their vast knowledge in different areas and help craft guidelines and recommendations. The entire process is expected to take two years, and the anticipated completion date is the end of 2018 with the guidelines being available for publication in early 2019. A VALUABLE RESOURCE The goal is to have the guidelines published in major medical journals to reach specialty fields and as many medical professionals as possible. The guidelines will be free to parents, caregivers, healthcare providers, and local Down syndrome organizations. "Parents have always been, by far, the best advocates for people with Down syndrome," Dr. McGuire said. "We've made certain to have a version available to families so they can use them to advocate for their sons and daughters." "Tens of thousands of people with Down syndrome reach adulthood each year, and this increases the importance of and need for evidence-based guidelines in this expanding group. Recommendations applied to a person with Down syndrome as a child may not be relevant in adulthood," said Kent McKelvey, M.D., who leads the Adult Medical Genetics and Down Syndrome Clinic at the University of Arkansas for Medical Sciences. "The presence of three copies of chromosome 21 has implications for development and aging in every organ system. This seems logical, and we have some understanding of the processes on a molecular level. We see patterns of disease predisposition with age, but we have not translated this into a comprehensive medical management approach. A systematic process such as this is needed to find the gaps in the evidence and order the current evidence into usable guidelines for primary care doctors." GLOBALDOWNSYNDROME.ORG 15

